Your browser doesn't support javascript.
loading
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
Pidala, Joseph; Kitko, Carrie; Lee, Stephanie J; Carpenter, Paul; Cuvelier, Geoffrey D E; Holtan, Shernan; Flowers, Mary E; Cutler, Corey; Jagasia, Madan; Gooley, Ted; Palmer, Joycelynne; Randolph, Tim; Levine, John E; Ayuk, Francis; Dignan, Fiona; Schoemans, Helene; Tkaczyk, Eric; Farhadfar, Nosha; Lawitschka, Anita; Schultz, Kirk R; Martin, Paul J; Sarantopoulos, Stefanie; Inamoto, Yoshihiro; Socie, Gerard; Wolff, Daniel; Blazar, Bruce; Greinix, Hildegard; Paczesny, Sophie; Pavletic, Steven; Hill, Geoffrey.
Afiliación
  • Pidala J; Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: joseph.pidala@moffitt.org.
  • Kitko C; Division of Pediatric Hematology/Oncology, Dpeartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Carpenter P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Cuvelier GDE; Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Holtan S; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
  • Flowers ME; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Cutler C; Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jagasia M; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gooley T; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Palmer J; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope, Duarte, California.
  • Randolph T; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Levine JE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dignan F; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • Schoemans H; Department of Hematology, University Hospitals Leuven and Department of Public Health, KU Leuven, Leuven, Belgium.
  • Tkaczyk E; Department of Veterans Affairs and Departments of Dermatology and Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Farhadfar N; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.
  • Lawitschka A; Stem Cell Transplantation Unit, St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria.
  • Schultz KR; Pediatric Hematology/Oncology/BMT, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Martin PJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sarantopoulos S; Division of Hematological Malignancies and Cellular Therapy, Duke Cancer Institute, Duke University Department of Medicine, Durham, North Carolina.
  • Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Socie G; Hematology and Bone Marrow Transplant Department, AP-HP Saint Louis Hospital and University of Paris, Paris, France.
  • Wolff D; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany.
  • Blazar B; Department of Pediatrics, Division of Blood & Marrow Transplantation & Cellular Therapy, University of Minnesota, Minneapolis, Minnesota.
  • Greinix H; Clinical Division of Hematology, Medical University of Graz, Graz, Austria.
  • Paczesny S; Department of Microbiology and Immunology and Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
  • Pavletic S; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hill G; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Transplant Cell Ther ; 27(8): 632-641, 2021 08.
Article en En | MEDLINE | ID: mdl-33836313
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article